WADA The 2022 Monitoring Program

WADA The 2022 Monitoring Program

The following substances are placed on the 2022 Monitoring Program*:

1. Anabolic Agents:
   In and Out-of-Competition: Ecdysterone
2. Beta-2 Agonists:
   In and Out-of-Competition: Salmeterol and vilanterol below the Minimum Reporting Level.
3. Stimulants:
   In-Competition only: Bupropion, caffeine, nicotine, phenylephrine,
   phenylpropanolamine, pipradrol and synephrine.
4. Narcotics:
   In-Competition only: Codeine, hydrocodone and tramadol.
   
   

* The World Anti-Doping Code (Article 4.5) states: “WADA, in consultation with Signatories and governments, shall establish a monitoring program regarding substances which are not on the Prohibited List, but which WADA wishes to monitor in order to detect potential patterns of misuse in sport.”